Human Placenta and Markers of Heavy Metals Exposure
http: //dx.doi.org/10.1289/ehp.1206061 In their review, Esteban-Vasallo et al. (2012) discussed the use of human placenta to evaluate bio markers of exposure to heavy metals. They correctly concluded that the use of placental tissue specimens to assess heavy metal exposure is actually under used. Surprisingly, they did not mention the well-documented relationship between mercury released from mercury-containing dental amalgam fillings and mercury disposition in placental tissues (Clarkson and Magos 2006; Gundacker and Hengstschläger 2012; Richardson et al. 2011) .
Studies have suggested an association between mercury levels in placental tissues and the observed mercury dental amalgams in women (Ask et al. 2002; Palkovicova et al. 2008; Richardson et al. 2011) . Elevated placental mercury levels have been reported in dental workers who, throughout pregnancy, were exposed to mercury vapor (Hg 0 ) released during preparation of mercury amalgam in dental offices (Guzzi and Pigatto 2007; Wannag and Skjaeråsen 1975) . As noted by Drasch et al. (1994) , the motherto-fetus transfer of mercury Hg 0 from amalgams has been reported in human autopsy samples, and elevated levels of total mercury have been observed in the brain, liver, and kidney of human fetuses; these levels have been linked to the number of maternal amalgam-restored surfaces.
Trans placental exposure to heavy metals may affect child growth and cause neurodevelopmental delays. Thus, further efforts should be made to measure and quantify maternal exposure to heavy metals in placenta to estimate environmental prenatal exposure. (Esteban-Vasallo et al. 2012 ). We understand their concern regarding mercury amalgams; however, the purpose of our review was to summarize the available information on total mercury, cadmium, and lead levels in human placental tissue, obtained from studies that reported original quantitative data. Published evidence suggests a possible association between mercury released from mercury-containing dental amalgam fillings and levels of this metal in diverse fetal tissues (kidney, brain, and cord blood) (Drasch et al. 1994) . In contrast, studies focusing on human placenta and amalgams are scarce and their results inconsistent. The only two studies included in our review that assessed a possible relationship between dental fillings and total mercury-a small study in Taiwan (46 women) (Hsu et al. 2007 ) and another in Jamaica (52 women) (Grant et al. 2010 )-found no association. Only Ask et al. (2002) reported higher mercury levels in mothers with a higher number of fillings, but they studied inorganic mercury and not total mercury.
Human
None of the studies mentioned by Pigatto et al. in their letter (Clarkson and Magos 2006; Gundacker and Hengstschlager 2012; Richardson et al. 2011) includes original data, although we did identify an additional reference from those articles that might provide more data on this issue, a symposium abstract by Ursinyova et al. (2006) . In this abstract, the authors described a significant correlation between the number of amalgams and placental mercury levels in 409 women; however, these findings have not yet been published in a full report that would allow us to better evaluate the results. In addition, Wannag and Skjaeråsen (1975) seemed to provide original information, but we were unable to find this paper for our review. In this context, we have to disagree with Pigatto et al.; in our opinion, the association between mercury exposure from dental amalgam fillings and levels of this metal in human placenta cannot yet be considered as well-established.
A 11 (Barnes et al. 2010; Kharitonov and Barnes 2001 ). Factors such as particle size, hygro scopicity, composition, and concentration; lung function parameters; and environ mental temperature and humidity Gangamma 2006, 2009) , which vary across experimental locations and between participants, modify particle deposition sites in the lung. These changes in the deposition site may influence the amount of NO exhaled. In their paper, Strak et al. (2012) did not discuss how these parameters influenced their conclusions. Thus, how the linear regression model they used accounts for these influences needs to be explained. Inflammation in the lung resulting from air pollution exposure involves various cell types, such as epithelial cells in upper airways and macrophages and recruited neutrophils in the lower respiratory tract. A significant source of exhaled NO is epithelial cells in the upper airways, which are associated with eosinophilic inflammation (Barnes et al. 2010; Kharitonov and Barnes 2001) . Many components of particulate matter (PM), such as endotoxin or bacteria, induce neutrophil inflammation in the lung, but the effects of these components may not be reflected in the concentration of exhaled NO. Thus, FE NO measurements as a marker of inflammation could easily be misinterpreted by attributing a particular part of the total inflammatory response within the lung to air pollution. Strak et al. (2012) did not discuss such possibilities.
In their article, Strak et al. (2012) did not provide sufficient details about the NIOX MINO monitor (Aerocrine 2010) they used to measure exhaled NO concentration. I assume that NO measurement involves flow measurement and diffusion of NO to a sensor. Temperature and humidity of exhaled air or body temperature of the subjects likely interfere with these opera tions. Strak et al. did not describe any of these parameters or how they may interfere with NO measurement. Moreover, the absolute values of FE NO observed during the experiments are not readily available. However, in the "Discussion," Strak et al. indicated that the observed variations between FE NO measure ments that are associated with particle number concentration (PNC) were most likely within the range of 5-15%. The technical specification of the instrument used for NO measure ment has precision values of 5 ppb or 10% for concentrations > 30 ppb (Aerocrine 2010) . Strak et al. used the difference between two sets of readings (preexposure and post exposure) as the input data for regression calculations. Thus, measurement error associated with the calculations could be much higher than that for a single set of measurements. Therefore, many of the observed differences in NO values were likely to fall within the error range of the instrument. Strak et al. should have discussed the propagation of error in the measurements or provided sufficient experimental data on the precision of the measurements. They should also have explained how the regression analysis is not biased by such instrument errors. Strak et al. (2012) reported measurement of PNC with a condensation particle counter (CPC model 3007; TSI 2007), but their Table S2 did not report the accuracy or limit of detection of this instrument. CPC measure ment depends on parameters such as ion concentration and particle composition, but because the measurements in the paper were from different environments, it is likely that these parameters varied significantly across the sites. Moreover, the CPC has a low sampling flow rate, and it is not clear whether this sampling rate is suitable for ambient measure ment (aspiration efficiency in case of fluctuations in ambient wind velocity).
Overall, the article is an excellent attempt by Strak et al. (2012) to use non invasive methods to understand the acute response of the respiratory system in response to air pollution exposure. However, a careful explanation of theory behind the experiments, experimental design, and limitations of measure ment methods (if any) should have been discussed in the article.
